---
$id: https://graph.org.ai/products/commodity/51141561
$type: Product
source: UNSPSC
code: "51141561"
title: "Ezogabine or retigabine"
class: "51141500"
classTitle: "Anticonvulsants"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ezogabine or retigabine

**UNSPSC Code**: 51141561
**Class**: [Anticonvulsants](Anticonvulsants.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anticonvulsant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 12G01I6BBU. European Medicines Agency schedules Retigabine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10291MIG. Ezogabine generally arises in the molecular formula C16H18FN3O2. The term 'ezogabine' is a European Medicines Agency European Public Assessment Report System designation. Ezogabine or retigabine bears US NLM identifiers UMLS ID C0530684 and NCI Concept Code C72839. SMILES: FC1CCC(CNC2CC(N)C(NC(=O)OCC)CC2)CC1.

